Acute graft-vs-host disease: pathobiology and management.
about
Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemiaColony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemiaThe role of colony stimulating factors administered for prevention and treatment of infectious complications in patients with acute myelogenous leukemiamicroRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cellsBone Marrow GvHD after Allogeneic Hematopoietic Stem Cell TransplantationDiagnosis of Atopic Dermatitis: Mimics, Overlaps, and ComplicationsThe Dark Side of the Force - Constraints and Complications of Cell Therapies for StrokeHost-reactive CD8+ memory stem cells in graft-versus-host diseaseHigh-content flow cytometry and temporal data analysis for defining a cellular signature of graft-versus-host disease.Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan.Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantationKinetics of IFN-γ and IL-17 Production by CD4 and CD8 T Cells during Acute Graft-versus-Host Disease.NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).Use of mesenchymal cells to modulate immune suppression and immune reconstruction in a patient with aplastic anemia complicated by invasive sino-orbital aspergillosisIdentification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host diseasePathogenesis and management of graft-versus-host disease.Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in miceBlood stem cell transplantation for breast cancer: new approaches using pre- peri- post-transplant immunotherapy.Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo.Stem cells in clinical practice: applications and warnings.Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host diseaseGraft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.Antibody- and aptamer-strategies for GvHD prevention.Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host Disease.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Acute graft versus host disease following liver transplantation: the enemy within.Clinical implications of T cell receptor repertoire analysis after allogeneic stem cell transplantation.Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.CD34 + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.Overview of T-cell depletion in haploidentical stem cell transplantation.Engineering T cells for cancer therapy.A characterization of the oral microbiome in allogeneic stem cell transplant patients.Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host diseaseFulminant gastrointestinal graft-versus-host disease concomitant with cytomegalovirus infection: case report and literature reviewOral chronic graft-versus-host disease: current pathogenesis, therapy, and researchDelta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.Allorecognition and the alloresponse: clinical implications.Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation.
P2860
Q24202698-EE6656CC-D825-4035-88DE-0BEA5BA63667Q24234458-A299496B-7478-4701-AE95-B68A2484D7A7Q24241455-6FC7B8E6-5DFA-442C-B19E-0F04272B0317Q24648506-9B2E9385-C677-48C2-A055-C3F6FB2B1895Q26749553-3A35DC38-DCA6-4284-94F5-D8B983CB0A6FQ26799526-14CBFE27-C1A0-4198-B57C-5DFBA4B16C95Q26800181-C549DD65-2847-4346-BB64-CF9989016D18Q28281894-F6B7B535-50E4-438E-AB2B-1710BA16E425Q31113879-4648183C-EB4E-43A1-9E26-0B7ED942EAD9Q33394786-B3293FFE-E8EA-4DD1-9509-C95AF2171464Q33564445-191C1A77-1340-467F-A039-6F7819BE5D68Q33619021-E0C8CDE6-C24D-4AB0-89F3-81D8DDB4D094Q33887452-6E8D8011-9D0E-4760-8F4A-A80748E2D906Q33914006-EBBE7F31-CC2A-4112-B337-092FB09262E2Q33914855-146B2C0D-0550-436F-83D5-45E1AAD096FDQ34033248-A194F4F0-4896-440C-A000-4A30304FFDB9Q34077479-94CCFC89-2B26-4F78-AE82-64A7DD81FE75Q34276582-633EBCF4-9BF6-43BD-8F6A-C2B74C92A0EFQ34452719-C5ACD584-8FD3-4E82-A55E-26237F7B3EBBQ34489151-28058603-5F58-4017-BCBC-81B98A74EFCEQ34552765-8F4BA8F9-4828-4A2F-8A33-AAA33EAA742DQ34667586-92370BB3-A9E9-45D5-99CD-CDA059FDBF35Q34834459-09788098-EB3C-4A2D-9430-2912DADE558BQ34885269-61936741-FB23-4E48-A47A-2683E580AE26Q34979429-EEF95DEC-ED49-456C-BAEC-1CE1668EA892Q35142329-B420FB1E-9FE9-4D81-A0E8-79937B580CD4Q35691919-2EE45264-01A1-46FF-96F5-BBDF2F860FDBQ35809452-C8DB4B87-B743-4C49-A4A5-6F85F2259872Q35917157-0F6C5AEC-C48F-44CF-80CC-32B6A70B3D71Q35994928-DFB5E1C2-686A-4ECD-B741-CFDD39A2CE20Q36159937-AD25E7D0-8BEA-4DCE-A29B-45570A1092A3Q36298319-E74D2493-15C0-4231-ABCD-D7AB8DFFFFE4Q36353589-23982DAC-2C1F-48E6-9B42-A2A21DFF396FQ36505142-3E9242CA-B719-47C3-916C-D2F069AD2853Q36572542-23C25531-3D24-4FA8-9558-85489B17AB28Q36579263-BBA4B982-1A29-4A8D-91CD-262481289B4BQ36717891-2CDA6CB3-7E20-485E-BD4D-F27AE9B33CF0Q36820105-BD343885-0A11-4B35-80B2-FE199E9394A2Q36835126-950CE459-6277-456B-BFC7-B4CCF7EC6418Q36867429-5D2B5FF1-D625-417B-9564-8D0C5A68FAE8
P2860
Acute graft-vs-host disease: pathobiology and management.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Acute graft-vs-host disease: pathobiology and management.
@ast
Acute graft-vs-host disease: pathobiology and management.
@en
type
label
Acute graft-vs-host disease: pathobiology and management.
@ast
Acute graft-vs-host disease: pathobiology and management.
@en
prefLabel
Acute graft-vs-host disease: pathobiology and management.
@ast
Acute graft-vs-host disease: pathobiology and management.
@en
P2093
P1476
Acute graft-vs-host disease: pathobiology and management.
@en
P2093
P304
P356
10.1016/S0301-472X(00)00677-9
P577
2001-03-01T00:00:00Z